Abbott Laboratories (ABT) Other Non-Current Assets (2009 - 2018)

Abbott Laboratories has reported Other Non-Current Assets for 10 years, with the latest figure at $17.0 million in Q4 2018.

• Quarterly Other Non-Current Assets fell 90.34% year-over-year to $17.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $17.0 million (down 90.34% YoY) and the FY2018 annual result came in at $17.0 million, down 90.34% from the prior year.
• Other Non-Current Assets slipped to $17.0 million in Q4 2018 per ABT's latest filing, from $19.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $3.3 billion in Q4 2014 and troughed at $17.0 million in Q4 2018.
• A 5-year average of $1.4 billion and a median of $1.4 billion in 2015 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2016 and 2017: Other Non-Current Assets soared 2521.9% in 2016, then plunged 97.95% in 2017.
• Over 5 years, Other Non-Current Assets stood at $3.3 billion in 2014, then tumbled by 96.81% to $105.0 million in 2015, then jumped by 2521.9% to $2.8 billion in 2016, then tumbled by 93.61% to $176.0 million in 2017, then sank by 90.34% to $17.0 million in 2018.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $17.0 million, $19.0 million, and $121.0 million for Q4 2018, Q3 2018, and Q2 2018 respectively.